Rapport Therapeutics, Inc. Common Stock (RAPP) Earning

$12.72

north_east
$0.21 (1.68%)
Day's range
$12.52
Day's range
$13.52
Actual EPS
RAPP Earnings Estimates and Actuals by Quarter$0$0-$0.5-$0.5-$1-$1-$1.5-$1.5Q2 2024Q2 2024Q3 2024Q3 2024Q4 2024Q4 2024Q1 2025Q1 2025Q2 2025Q2 2025Q3 2025Q3 2025Q4 2025Q4 2025Q1 2026Q1 2026Q2 2026Q2 2026Q3 2026Q3 2026Q4 2026Q4 2026
Download SVG
Download PNG
Download CSV

Rapport Therapeutics, Inc. Common Stock Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 1 -$0.71 -$0.71 -$0.71
Q2 2025 1 -$0.80 -$0.80 -$0.80
Q3 2025 1 -$0.87 -$0.87 -$0.87
Q4 2025 1 -$0.98 -$0.98 -$0.98
Q1 2026 1 -$0.96 -$0.96 -$0.96
Q2 2026 1 -$0.95 -$0.95 -$0.95
Q3 2026 1 -$1.22 -$1.22 -$1.22
Q4 2026 1 -$1.25 -$1.25 -$1.25

Rapport Therapeutics, Inc. Common Stock Earnings Date And Information

Rapport Therapeutics, Inc. Common Stock last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.5 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Rapport Therapeutics, Inc. Common Stock has generated $0 earnings per share over the last year ($-0.21 diluted earnings per share) and currently has a price-to-earnings ratio of -6.16. Rapport Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.

Rapport Therapeutics, Inc. Common Stock Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/07/2024 Q3 2024 -$0.57 -$0.50 0.07 $0 $0
08/08/2024 Q2 2024 -$0.68 -$0.50 0.18 $0 $0
03/30/2024 Q1 2024 -$0.64 $0
12/31/2023 Q4 2023 $0.00 $0
09/30/2023 Q3 2023 -$0.36 $0
06/28/2023 Q2 2023 -$0.18 $0
03/30/2023 Q1 2023 -$0.17 $0
 

Rapport Therapeutics, Inc. Common Stock Earnings: FAQ's

When is Rapport Therapeutics, Inc. Common Stock's earnings date?

Rapport Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.

Did Rapport Therapeutics, Inc. Common Stock beat their earnings estimates last quarter?

In the previous quarter, Rapport Therapeutics, Inc. Common Stock (:RAPP) reported $-0.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.07.

How can I listen to Rapport Therapeutics, Inc. Common Stock's earnings conference call?

The conference call for Rapport Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.

How can I read Rapport Therapeutics, Inc. Common Stock's conference call transcript?

The conference call transcript for Rapport Therapeutics, Inc. Common Stock's latest earnings report can be read online.

How much profit does Rapport Therapeutics, Inc. Common Stock generate each year?

Rapport Therapeutics, Inc. Common Stock (:RAPP) has a recorded net income of $0. Rapport Therapeutics, Inc. Common Stock has generated $-0.21 earnings per share over the last four quarters.

What is Rapport Therapeutics, Inc. Common Stock's price-to-earnings ratio?

Rapport Therapeutics, Inc. Common Stock (:RAPP) has a price-to-earnings ratio of -6.16 and price/earnings-to-growth ratio is 0.66.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED